drugset / Trial / NCT01190865

Study of Survival Duration for Donor Skin Cells in Skin Biopsy Wounds

NCT01190865

Phase 1 Completed 28 enrolled Healthpoint
NaSingle-groupOpen-labelTreatment

Summary

The goal for this study is to examine the persistence of growth arrested,allogeneic,male-donor keratinocytes and fibroblasts when applied as product HP802-247 to the surface of acute excisional wounds in health female volunteers, as measured using Y-STR for detection of Y-chromosome.

Timeline

Start
2010-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HP802-247 Cell therapy 260 ml Topical

Indications

No indication recorded.